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Abstract The incidence of esophageal squamous cell
carcinoma (ESCC) is very high in northeastern Iran. Pre-
viously, we reported a strong familial component of ESCC
among Turkmens, who constitute approximately one-half
of the population of this region. We hypothesized that the
genes which cause Fanconi anemia might be candidate
genes for ESCC. We sequenced the entire coding regions
of 12 Fanconi anemia genes in the germline DNA of 190
Turkmen cases of ESCC. We identified three heterozygous
insertion/deletion mutations: one in FANCD2 (p.Val1233-
del), one in FANCE (p.Val311SerfsX2), and one in FANCL
(p.Thr367AsnfsX13). All three patients had a strong family
history of ESCC. In addition, four patients (out of 746
tested) were homozygous for the FANCA p.Ser858Arg
mutation, compared to none of 1,373 matched controls
(OR = 16.7, 95% CI = 6.2–44.2, P = 0.01). The
p. Lys3326X mutation in BRCA2 (also known as Fanconi
anemia gene FANCD1) was present in 27 of 746 ESCC
cases and in 16 of 1,373 controls (OR = 3.38, 95%
CI = 1.97–6.91, P = 0.0002). In summary, both hetero-
zygous and homozygous mutations in several Fanconi
anemia-predisposing genes are associated with an
increased risk of ESCC in Iran.
Introduction
Esophageal cancer is the eighth most common cancer in the
world and is a significant global health problem (Parkin et al.
2005). The 5-year survival rate for patients with esophageal
cancer is 10–16% (Parkin et al. 2005). A region in north-
eastern Iran at the Caspian Sea littoral has a very high
incidence of esophageal cancer (Saidi et al. 2000; Semnani
et al. 2006), most of which are squamous cell carcinomas.
Previously, we reported a strong familial component of
esophageal squamous cell carcinoma (ESCC) among
Turkmen (Akbari et al. 2006). Turkmens constitute one-half
of the population in this region. The lifetime risk of cancer
was 14% for all individuals in the population and was 34%
for those with a first-degree relative with esophageal cancer
(HR = 2.3, 95% CI = 1.7–3.1, P = 3 9 10-8).
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